210 related articles for article (PubMed ID: 12632187)
1. Cholesterol modifies the gating of Kv1.3 in human T lymphocytes.
Hajdú P; Varga Z; Pieri C; Panyi G; Gáspár R
Pflugers Arch; 2003 Mar; 445(6):674-82. PubMed ID: 12632187
[TBL] [Abstract][Full Text] [Related]
2. Methyl-beta-cyclodextrin reversibly alters the gating of lipid rafts-associated Kv1.3 channels in Jurkat T lymphocytes.
Pottosin II; Valencia-Cruz G; Bonales-Alatorre E; Shabala SN; Dobrovinskaya OR
Pflugers Arch; 2007 May; 454(2):235-44. PubMed ID: 17242956
[TBL] [Abstract][Full Text] [Related]
3. Functional consequences of Kv1.3 ion channel rearrangement into the immunological synapse.
Tóth A; Szilágyi O; Krasznai Z; Panyi G; Hajdú P
Immunol Lett; 2009 Jun; 125(1):15-21. PubMed ID: 19477198
[TBL] [Abstract][Full Text] [Related]
4. NH2-terminal inactivation peptide binding to C-type-inactivated Kv channels.
Kurata HT; Wang Z; Fedida D
J Gen Physiol; 2004 May; 123(5):505-20. PubMed ID: 15078918
[TBL] [Abstract][Full Text] [Related]
5. Membrane cholesterol modulates Kv1.5 potassium channel distribution and function in rat cardiomyocytes.
Abi-Char J; Maguy A; Coulombe A; Balse E; Ratajczak P; Samuel JL; Nattel S; Hatem SN
J Physiol; 2007 Aug; 582(Pt 3):1205-17. PubMed ID: 17525113
[TBL] [Abstract][Full Text] [Related]
6. The influence of membrane lipid metabolites on lymphocyte potassium channel activity.
Teisseyre A; Michalak K; Kuliszkiewicz-Janus M
Cell Mol Biol Lett; 2002; 7(4):1095-109. PubMed ID: 12511977
[TBL] [Abstract][Full Text] [Related]
7. The glycosylation state of Kv1.2 potassium channels affects trafficking, gating, and simulated action potentials.
Watanabe I; Zhu J; Sutachan JJ; Gottschalk A; Recio-Pinto E; Thornhill WB
Brain Res; 2007 May; 1144():1-18. PubMed ID: 17324383
[TBL] [Abstract][Full Text] [Related]
8. Kv1.2-containing K+ channels regulate subthreshold excitability of striatal medium spiny neurons.
Shen W; Hernandez-Lopez S; Tkatch T; Held JE; Surmeier DJ
J Neurophysiol; 2004 Mar; 91(3):1337-49. PubMed ID: 13679409
[TBL] [Abstract][Full Text] [Related]
9. Effects of Kv1.1 channel glycosylation on C-type inactivation and simulated action potentials.
Sutachan JJ; Watanabe I; Zhu J; Gottschalk A; Recio-Pinto E; Thornhill WB
Brain Res; 2005 Oct; 1058(1-2):30-43. PubMed ID: 16153617
[TBL] [Abstract][Full Text] [Related]
10. Modulation of voltage-gated potassium channels in human T lymphocytes by extracellular glutamate.
Poulopoulou C; Markakis I; Davaki P; Nikolaou C; Poulopoulos A; Raptis E; Vassilopoulos D
Mol Pharmacol; 2005 Mar; 67(3):856-67. PubMed ID: 15718225
[TBL] [Abstract][Full Text] [Related]
11. Tityustoxin-K(alpha) blockade of the voltage-gated potassium channel Kv1.3.
Rodrigues AR; Arantes EC; Monje F; Stühmer W; Varanda WA
Br J Pharmacol; 2003 Jul; 139(6):1180-6. PubMed ID: 12871837
[TBL] [Abstract][Full Text] [Related]
12. Synergistic inhibition of the maximum conductance of Kv1.5 channels by extracellular K+ reduction and acidification.
Fedida D; Zhang S; Kwan DC; Eduljee C; Kehl SJ
Cell Biochem Biophys; 2005; 43(2):231-42. PubMed ID: 16049348
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the cloned delayed rectifier K+ channels, Kv1.5 and Kv3.1, by riluzole.
Ahn HS; Choi JS; Choi BH; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
Neuroscience; 2005; 133(4):1007-19. PubMed ID: 15964489
[TBL] [Abstract][Full Text] [Related]
14. The modulatory effect of zinc ions on voltage-gated potassium currents in cultured rat hippocampal neurons is not related to Kv1.3 channels.
Teisseyre A; Mercik K; Mozrzymas JW
J Physiol Pharmacol; 2007 Dec; 58(4):699-715. PubMed ID: 18195482
[TBL] [Abstract][Full Text] [Related]
15. [The function of voltage-gated potassium canals in T-lymphocytes under physiological and pathologic conditions].
Teisseyre A
Postepy Hig Med Dosw; 1999; 53(2):383-97. PubMed ID: 10355302
[TBL] [Abstract][Full Text] [Related]
16. Concatemers of brain Kv1 channel alpha subunits that give similar K+ currents yield pharmacologically distinguishable heteromers.
Sokolov MV; Shamotienko O; Dhochartaigh SN; Sack JT; Dolly JO
Neuropharmacology; 2007 Aug; 53(2):272-82. PubMed ID: 17637465
[TBL] [Abstract][Full Text] [Related]
17. Closed- and open-state binding of 4-aminopyridine to the cloned human potassium channel Kv1.5.
Bouchard R; Fedida D
J Pharmacol Exp Ther; 1995 Nov; 275(2):864-76. PubMed ID: 7473178
[TBL] [Abstract][Full Text] [Related]
18. Arachidonic acid potently inhibits both postsynaptic-type Kv4.2 and presynaptic-type Kv1.4 IA potassium channels.
Angelova PR; Müller WS
Eur J Neurosci; 2009 May; 29(10):1943-50. PubMed ID: 19453640
[TBL] [Abstract][Full Text] [Related]
19. Constitutive inactivation of the hKv1.5 mutant channel, H463G, in K+-free solutions at physiological pH.
Zhang S; Eduljee C; Kwan DC; Kehl SJ; Fedida D
Cell Biochem Biophys; 2005; 43(2):221-30. PubMed ID: 16049347
[TBL] [Abstract][Full Text] [Related]
20. Differential modulation of Kv1 channel-mediated currents by co-expression of Kvbeta3 subunit in a mammalian cell-line.
Bähring R; Vardanyan V; Pongs O
Mol Membr Biol; 2004; 21(1):19-25. PubMed ID: 14668135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
